NEW YORK, Oct. 21 (GenomeWeb News) - High Throughput Genomics today said that ProSkelia would use its ArrayPlate high-throughput screening technology in one of its drug discovery programs.
The ArrayPlate contains a generic Universal Array in each well of a standard 96-well microplate to simultaneously measure up to 100 DNA, RNA, or protein molecules, acording to High Throughput Genomics. Each of the five-element ArrayPlate kits ProSkelia purchased includes four target genes and one control gene.
The company did not provide financial terms of the agreement.